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Abstract
Background: The human epidermis is comprised of several layers of specialized epithelial cells called keratinocytes. Normal
homoeostasis of the epidermis requires that the balance between keratinocyte proliferation and terminal differentiation be
tightly regulated. The mammalian serine/threonine kinases (ROCK1 and ROCK2) are well-characterised downstream
effectors of the small GTPase RhoA. We have previously demonstrated that the RhoA/ROCK signalling pathway plays an
important role in regulation of human keratinocyte proliferation and terminal differentiation. In this paper we addressed the
question of which ROCK isoform was involved in regulation of keratinocyte differentiation.
Methodology and Principal Findings: We used RNAi to specifically knockdown ROCK1 or ROCK2 expression in cultured
human keratinocytes. ROCK1 depletion results in decreased keratinocyte adhesion to fibronectin and an increase in terminal
differentiation. Conversely, ROCK2 depletion results in increased keratinocyte adhesion to fibronectin and inhibits terminal
differentiation.
Conclusion: These data suggest that ROCK1 and ROCK2 play distinct roles in regulating keratinocyte adhesion and terminal
differentiation.
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Introduction
The human epidermis is comprised of several layers of
specialized epithelial cells called keratinocytes. As keratinocytes
are lost from the outermost epidermal layers, they are replaced
through a process of terminal differentiation in which keratino-
cytes in the basal layer exit the cell cycle, down-regulate adhesion
to the extracellular matrix (ECM) proteins of the basal lamina and
migrate upwards through the supra-basal, differentiated layers,
until they eventually reach the outermost cornified layer [1]. The
basal lamina is made up of various ECM proteins, including
fibronectin, collagens and laminins. Keratinocytes in the basal
layer of the epidermis adhere to these ECM proteins via integrin
adhesion receptors and there is considerable evidence that
adhesion to ECM plays a key role in regulating epidermal
function [1]. Disruption of integrin-ECM interactions results in
initiation of keratinocyte terminal differentiation in vitro [1–3].
Hence, normal epidermal function requires that the balance
between keratinocyte proliferation, adhesion to ECM proteins and
terminal differentiation be tightly regulated. Previous data from
our laboratory and others suggest that signalling though Rho
family GTPases is required for keratinocyte terminal differentia-
tion [4–6]. RhoA is a member of the Rho family of small GTPases
and acts as a molecular switch to regulate a plethora of cellular
processes including organisation of the actin cytoskeleton, cell
adhesion and motility and gene expression [7]. The best-
characterised downstream effectors of RhoA are the serine/
threonine kinases ROCK1 and ROCK2 (also known as ROKb
and ROKa, respectively) [8,9]. Both ROCK isoforms are
comprised of an N-terminal region, a kinase domain, a coiled-
coil domain containing a Rho binding site, a PH domain and a C-
terminal domain [10]. Both isoforms share a high amino acid
sequence identity, with 92% identity across their kinase domains.
However, the two kinases only share 65–70% sequence identity
across their PH domains, which may account for the observed
differences in cellular localisation of the two isoforms [8,9,11].
Most studies to date have either used over-expression of ROCK or
pharmacological inhibition of ROCK [4,12,13]. Neither of these
methods allows discrimination of isoform-specific functions.
Recently, functional differences between the two ROCK isoforms
have become more apparent. In vivo data show that, despite their
structural similarities, ROCK1 or ROCK2 expression cannot
compensate for loss of the other isoform during murine embryonic
development [14–16]. In vitro studies utilising ROCK isoform
specific RNAi knockdown in fibroblasts also suggest that ROCK1
and ROCK2 may have distinct, and sometimes opposing, roles in
the cell [11,17]. In this study we used RNAi to specifically
knockdown ROCK1 or ROCK2 expression in cultured keratino-
cytes and analysed adhesion to various ECM proteins and the
differentiation status of the cells. Our data suggest that both
ROCK isoforms play distinct and important roles in regulating
keratinocyte differentiation status and keratinocyte adhesion to the
ECM protein fibronectin.
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HaCaT keratinocytes were stably transfected with GFP-IRES-
shRNAmir constructs specifically targeting ROCK1 or ROCK2
or a non-silencing control nonsense mRNA sequence (NSC) to
generate HaCaT-ROCK1-KD, HaCaT-ROCK2-KD and Ha-
CaT-NSC cells respectively. A stable decrease in ROCK1
expression was observed in HaCaT-ROCK1-KD cells, compared
to HaCaT-NSC and HaCaT-ROCK2-KD cells (Figure 1A, B).
Similarly, a significant decrease in ROCK2 expression was
observed in HaCaT-ROCK2-KD cells, when compared to
HaCaT-NSC and HaCaT-ROCK1-KD cells (Figure 1C, D).
Depletion of ROCK1 or ROCK2 had no effect on expression of
the other, non-targeted, ROCK isoform (Figure 1A, C). To further
characterise these cell lines following ROCK isoform knockdown,
HaCaT-NSC, HaCaT-ROCK1-KD and HaCaT-ROCK2-KD
cell lysates were immunoblotted to assess changes in phosphory-
lation of two known ROCK targets - myosin phosphatase (MYPT)
and myosin light chain (MLC). Both ROCK1 and ROCK2 are
able to directly phosphorylate MYPT1 on threonine residue 696
Figure 1. ROCK isoform-specific knockdown affects phosphorylation of downstream targets. HaCaT-NSC, HaCaT-ROCK1-KD or HaCaT-
ROCK2-KD cell lysates were immunoblotted to assess ROCK1 expression (A) or ROCK2 expression (C). B and D show densitometric analysis of
knockdown of ROCK1 (B) or ROCK2 (D) relative to non-silencing (NSC) control cells and are the mean of 3 separate experiments (** p,0.01).
Phosphorylation of myosin phosphatase-1 residue Thr696 (p-MYPT) and myosin light chain residue Ser19 (p-MLC) were also analysed and data shown
are representative of 3 separate experiments (E).
doi:10.1371/journal.pone.0008190.g001
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ROCK2 [18–20]. Decreased MYPT phosphorylation was ob-
served in both HaCaT-ROCK1-KD and HaCaT-ROCK2-KD
cells when compared to HaCaT-NSC cells (Figure 1E). Consistent
with MLCpSer19 being a ROCK1 substrate but not a ROCK2
substrate, a decrease in phosphorylated MLC was observed in
HaCaT-ROCK1-KD cells, but not in HaCaT-ROCK2-KD or
HaCaT-NSC cells (Figure 1E). These results confirm that stable
knockdown of ROCK1 and ROCK2 expression in these HaCaT
keratinocyte cell lines is isoform specific and has functional
consequences in terms of phosphorylation of known downstream
effectors.
Previous work has established clear functional links between
adhesion to fibronectin, integrin signalling and keratinocyte
terminal differentiation. [1,2,21]. To assess the role of ROCK1
and ROCK2 in keratinocyte adhesion we analysed adhesion to
various extracellular matrix proteins. Following ROCK1 deple-
tion, a significant decrease in keratinocyte adhesion to full-length
fibronectin was observed when compared to HaCaT-NSC cells
(Figure 2A). In contrast, ROCK2 depletion resulted in a
significant increase in cell adhesion to fibronectin (Figure 2A).
Similar results were observed using recombinantly expressed
FIII9-10 integrin-binding domain of fibronectin as a ligand (Figure
S1). Adhesion to the ECM proteins collagen IV and laminin-332
(previously called laminin V) was also assessed. Both are known
keratinocyte ligands, but no significant differences in HaCaT
adhesion were observed following ROCK1 or ROCK2 knock-
down, when compared to HaCaT-NSC cells (Figure 2B, C). Over
the duration of the assay no obvious differences in cell morphology
were observed between any of the cell lines (data not shown).
Having observed clear differences in cell adhesion to
fibronectin between ROCK1 and ROCK2 depleted keratino-
cytes, we assessed the differentiation status of both cell lines.
HaCaT-NSC, HaCaT-ROCK1-KD and HaCaT-ROCK2-KD
cells were cultured for 2 days post-confluence to induce
differentiation and cells lysed and immunoblotted to assess
expression of basal and suprabasal keratins. Loss of the basal
keratinocyte marker, keratin 5, is observed during keratinocyte
differentiation and expression of keratin 5, was greatly reduced
following ROCK1 depletion when compared to HaCaT-NSC
cells (Figure 3A). Increased expression of keratin 10, a supra-
basal marker of keratinocyte terminal differentiation, was also
observed in HaCaT-ROCK1-KD cells (Figure 3A). Conversely,
expression of keratin 5 was increased, and expression of keratin
10 was decreased in HaCaT-ROCK2-KD cells, when compared
to HaCaT-NSC cells (Figure 3A). This would be consistent with
an inhibition of keratinocyte terminal differentiation following
ROCK2 depletion. To further characterise this differentiation
phenotype we used different RNAi methodology and an
alternative keratinocyte cell line to analyse spontaneous differ-
e n t i a t i o ni ns u b - c o n f l u e n tc e l l s. SCC12f cells are derived from a
squamous cell carcinoma but grow and differentiate in a manner
similar to that seen in normal primary keratinocytes and are a
well-established model for keratinocyte function [22]. We
transiently transfected SCC12f keratinocytes with siRNA oligos
targeted against ROCK1 and ROCK2. The target sequences
used were different to those targeted using the shRNAi vectors.
As a control, SCC12f cells were also transfected with non-
silencing control oligos (NSC). Following transient transfection
with siRNA oligos, sub-confluent SCC12f cells were cultured,
lysed and immunoblotted. As sho w ni nF i g u r e3 B ,w eo b s e r v e d
isoform-specific knockdown of ROCK1 and ROCK2 in SCC12f
cells although the knockdown of ROCK2 was not complete. To
assess the rate of spontaneous differentiation in these cells,
expression of the cornified envelope precursor involucrin, a
commonly used marker for differentiation, was analysed.
Transiently transfected, sub-confluent, SCC12f were fixed and
Figure 2. ROCK isoform-specific knockdown regulates cell
adhesion to fibronectin. Adhesion of HaCaT-NSC, HaCaT-ROCK1-KD
or HaCaT-ROCK2-KD to the extracellular matrix ligands fibronectin (A)
collagen IV (B) and laminin 332 (C) was analysed. The mean and
standard error of 3 separate experiments are shown in each case.
Statistical analysis was carried out using unpaired two-way Student’s T-
test (** p,0.01).
doi:10.1371/journal.pone.0008190.g002
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immunocytochemistry. siRNA-mediated knockdown of ROCK1
expression resulted in a 2-fold increase in the percentage of
cells expressing involucrin, when compared to NSC controls
(Figure 3C). In contrast, knockdown of ROCK2 expression
resulted in a significant decrease in the percentage of involucrin
expressing cells (Figure 3C and Figure S2). These data are
consistent with the changes in keratin 5 and keratin 10 expression
observed in HaCaT-ROCK1-KD and HaCaT-ROCK2-KD
cells (Figure 3A). Taken together, these data suggest that loss of
ROCK1 expression promotes keratinocyte terminal differentia-
tion and that loss of ROCK2 expression has the opposite effect,
inhibiting keratinocyte terminal differentiation.
Discussion
Our data confirm that both ROCK isoforms are expressed in
cultured human keratinocytes and that each isoform can be
specifically depleted, with no effect on the expression of the other
(Figure 1A–D). We observed that depletion of either ROCK1 or
ROCK2 results in decreased phosphorylation of MYPT on
Thr696 (Fig 1E). This is consistent with published data where
both ROCK1 and ROCK2 have been reported to phosphorylate
MYPT on Thr696, leading to its inactivation [18–20]. In contrast,
we observed a specific loss in phosphorylation of MLC on Ser19 in
ROCK1 depleted cells but not in ROCK2 depleted cells
(Figure 1E). Again, this is consistent with recent studies describing
MLC as a ROCK1-specific target [11,14,23]. This implies that
continued expression of one isoform cannot compensate for the
loss of the other, suggesting specific functional differences in
human keratinocytes. Previous work from our laboratory has
shown that the Rho/ROCK signalling pathway is important in
regulating keratinocyte function [4]. Here we have shown that the
two ROCK isoforms have distinct roles in the regulation of
keratinocyte adhesion to fibronectin (Figure 2A). One possible
explanation for the differences in adhesion to fibronectin in
ROCK1-depleted keratinocytes might be a consequence of loss of
actinomyosin contractility affecting adhesion complexes. Howev-
er, under the conditions used in the adhesion assays (1 hour
adhesion) we observed no differences in adhesion complex size
(data not shown). The role of ROCK1 function in adhesion to
fibronectin has been analysed in rat embryo fibroblasts which,
when seeded on fibronectin, displayed significantly higher
ROCK1 activity than ROCK2 [11]. This led the authors to
conclude that the adhesion process has a particular requirement
for ROCK1 [11]. This would appear to be consistent with our
data in which we see a decrease in adhesion to fibronectin in
ROCK1-depleted keratinocytes but it is worth noting that
adhesion to fibronectin-coated beads was unaffected in ROCK1-
depleted fibroblasts [17]. Alternatively, it might be a consequence
of altered fibronectin matrix assembly, as has been observed in
fibroblasts [17]. However, this is unlikely to have been a factor in
the relatively short period of adhesion used in our assays. It is
unclear why adhesion to fibronectin is affected by depletion of
ROCK1 or ROCK2 but adhesion to laminin-332 or collagen IV,
both of which are known keratinocyte ECM ligands, is unaffected
(Figure 2B,C). One possibility is that ROCK1 and ROCK2
regulate expression and/or function of keratinocyte fibronectin
receptors (e.g. a5b1 integrin). We have analysed expression and
function of the most abundant fibronectin-binding integrin, a5b1,
but did not observe any consistent or significant changes in
expression or activity (data not shown). This does not rule out the
possibility that other fibronectin-binding integrins (e.g. avb5) are
involved and this is currently being investigated.
Figure 3. ROCK isoform-specific knockdown regulates kerati-
nocyte differentiation. A, HaCaT-NSC, HaCaT-ROCK1-KD or HaCaT-
ROCK2-KD cells were cultured for 2 days post-confluence and lysed.
Expression of keratin 5, keratin 10 and tubulin were assessed by
immunoblotting (A). SCC12f keratinocytes were transiently transfected
with siRNA oligos to specifically knockdown ROCK1 or ROCK2 As a
control SCC12f cells were transfected with a non-silencing control oligo
(NSC). Cells were lysed and immunoblotted to assess ROCK isoform
knockdown (B) or fixed and immunostained to assess involucrin
expression (C). The means and standard errors from 3 separate
experiments are shown. Statistical analysis was carried out using
unpaired two-way Student’s T-test, ** p,0.01, * p,0.05.
doi:10.1371/journal.pone.0008190.g003
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expression of the constitutively active kinase domain of ROCK2
in human keratinocytes promoted terminal differentiation [4].
Consistent with this, inhibition of ROCK using Y-27632
inhibited keratinocyte differentiation [4]. However, as these
experiments involved over-expression of the kinase domain
alone, it is possible that the constitutively active mutant would be
targeted inappropriately withint h ec e l l .F u r t h e r m o r e ,Y - 2 7 6 3 2
inhibits both isoforms of ROCK as well as other kinases such as
PRK2 and PKN [13,24]. The approach we have adopted here,
using ROCK isoform-specific RNAi, allows a more detailed
a n a l y s i so ft h er o l eo fR O C Ki nk e r a t i n o c y t et e r m i n a l
differentiation. Interestingly, we found that the two ROCK
isoforms have opposing roles in regulating keratinocyte terminal
differentiation. Knockdown of ROCK1 promotes keratinocyte
terminal differentiation whereas knockdown of ROCK2 has the
opposite effect and inhibits keratinocyte terminal differentiation
(Figure 3A,C). One possible explanation for these observations is
that a ROCK1-interacting protein is involved in promoting
differentiation and one candida t eh e r em i g h tb eR h o E / R n d 3 ,
which binds specifically to ROCK1, and has recently been linked
to the stratification and differentiation of human keratinocytes
[6,25].
In summary, we have used RNAi to specifically knockdown
ROCK1 or ROCK2 expression in cultured keratinocytes. The
data presented in this paper support our previous report of a
pivotal role for ROCK signalling in keratinocyte function and
extend those observations by reporting that ROCK1 and ROCK2




Primary antibodies used were: involucrin (SY-5, Abcam,
Cambridge, UK); ROCK1 (H-85, Santa Cruz, USA); ROCK2
(BD Transduction Laboratories, Oxford, UK); tubulin (T6199,
Sigma, MO, USA); phospho-MYPT1 (Thr-696-MYPT1, Upstate
Cell Signalling Solutions, USA); phospho-MLC (Thr18/Ser19-
Myosin Light Chain 2, Cell Signaling Technology, Inc., MA,
USA); total MLC (Myosin Light Chain, MY-21. Sigma, MO,
USA); keratin 10 (Thermo Fisher Scientific, CA, USA); keratin 5
(Abcam, Cambridge, UK); pan-keratin (Zymed, South San
Francisco, CA, USA). Secondary antibodies were purchased from
Jackson Immunoresearch (West Grove, PA, USA). All other
reagents were purchased from Sigma.
Cell Culture
SCC12f keratinocytes [22] were co-cultured with mitotically
inactivated feeder fibroblasts using the method of Rheinwald and
Green as described elsewhere [26]. HaCaT keratinocytes [27]
were cultured in DMEM media containing 5% FBS and 1%
penicillin/streptomycin. Cell culture medium and reagents were
purchased from Invitrogen.
Plasmids and siRNA Oligos
HaCaT immortalized human keratinocytes were stably trans-
fected with GFP-IRES-shRNAmir constructs purchased from
Open Biosystems, UK, to knockdown ROCK1 (RHS4186-
97556976 pGinZeo), ROCK2 (RHS4430-98854581 pGipZ) or a
nonsense mRNA sequence (Non-Silencing Control) (RHS4346
pGipZ) using the Amaxa HaCaT nucleofection solution V (VCA-
1003, Amaxa Inc., MD, USA) according to the manufacturers
instructions. Plasmid-expressing HaCaT cells were cultured in
1.5 mg/ml puromycin or 400 mg/ml G418 as appropriate. Cells
were lysed at sub-confluence or 2 days post-confluence, as
described in the text. SCC12f keratinocytes were transiently
transfected with siRNA oligos targeting ROCK1 (ON-TARGET-
plus siRNA J-003536-06-0020, J-003536-07-0020, Thermo Sci-
entific, USA), ROCK2 (S102223746, S102223753, QIAGEN,
UK) or a non-silencing control sequence (S103650325, QIAGEN,
UK) using Lipofectamine RNAi MAX reagent (Invitrogen)
according to manufacturers instructions.
Involucrin Immunostaining
SCC12f keratinocytes were fixed with 4% paraformaldehyde in
PBS, permeablised with ice-cold methanol and stained with
antibodies against involucrin and pan-keratin as described
elsewhere [4,28]. Cells were stained with pan-keratin antibody
to ensure only keratinocytes (and not residual fibroblasts) were
analysed. Cells were visualized using a Leica DMRB microscope
equipped with a Hamamatsu ORCA camera, and images were
captured and processed using OpenLab software (Improvision).
For each immunostaining, the same exposure time was used to
capture images. The percentage of involucrin positive cells
compared to the total number of pan-keratin positive cells was
calculated and expressed as fold change, with the mean and
standard error of 3 separate experiments given. For each
experiment a minimum of 3 fields of view (minimum of 150 cells
per field) per condition were scored and all experiments were
scored blind.
SDS-PAGE and Western Blotting
Protein lysates were prepared in 3x Laemmli buffer, separated
by SDS-PAGE, and immunoblotted as described elsewhere [12].
All experiments were performed on three separate occasions, with
representative blots shown.
Adhesion Assays
Keratinocytes were re-suspended in serum-free medium and
plated in 96-well plates (Immulon II; Thermo Electron) previously
coated with either full length fibronectin (Sigma) or collagen IV
(Sigma) diluted in PBS or a laminin-332-enriched substrate and
blocked in bovine serum albumin/PBS for 1 h. After incubation
for 1 h, non-adherent cells were removed by washing in PBS,
and numbers of adherent cells were assessed by analysis of
endogenous hexosaminidase activity [29]. The laminin-332
enriched substrates were prepared as described elsewhere [30].
Statistical analysis was performed using unpaired two-way
Student’s T-tests.
Supporting Information
Figure S1 ROCK isoform-specific knockdown regulates cell
adhesion to the FIII9-10 integrin-binding domain of fibronectin.
Adhesion of HaCaT-NSC, HaCaT-ROCK1-KD or HaCaT-
ROCK2-KD to recombinant FIII9-10 was analysed. The mean
and standard error of 3 separate experiments are shown. Statistical
analysis was carried out using unpaired two-way Student’s T-test
(** p,0.01, * p,0.05).
Found at: doi:10.1371/journal.pone.0008190.s001 (2.65 MB TIF)
Figure S2 ROCK isoform-specific knockdown regulates kera-
tinocyte differentiation. SCC12f keratinocytes were transiently
transfected with siRNA oligos to specifically knockdown ROCK1
or ROCK2 As a control SCC12f cells were transfected with a
non-silencing control oligo (NSC). Cells were fixed and immu-
nostained to assess involucrin expression. Cells were also stained
ROCK Function in Keratinocytes
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analysis.
Found at: doi:10.1371/journal.pone.0008190.s002 (3.67 MB TIF)
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